Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 15 of 15 entries
View as:

A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Efficacy and Safety of SHR-1918 in Patients With Homozygous Familial Hypercholesterolemia

Phase: N/A Priority: Normal
NCT ID: NCT06723652 Org: User:
Start: 02/13/25 End: 12/31/25 Due: 12/31/26

Evaluate the Efficacy and Safety of SHR-1918 in Patients With Homozygous Familial Hypercholesterolemia

Phase: N/A Priority: Normal
NCT ID: NCT06009393 Org: User:
Start: 09/24/23 End: 08/18/24 Due: 08/18/25

The Efficacy and Safety of HRS8179 in Severe Cerebral Edema Following Large Hemispheric Infarction

Phase: N/A Priority: Normal
NCT ID: NCT06732648 Org: User:
Start: 02/07/25 End: 09/30/27 Due: 09/30/28

Single Ascending Dose and Multiple Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SHR-1816 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05330208 Org: User:
Start: 05/18/22 End: 09/05/22 Due: 09/05/23

Safety and Tolerability of SHR-1918 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05432544 Org: User:
Start: 06/27/22 End: 12/12/23 Due: 12/12/24

A Study to Evaluate the Efficacy and Safety of SHR-2004 Injection in Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery

Phase: N/A Priority: Normal
NCT ID: NCT06220123 Org: User:
Start: 01/31/24 End: 07/31/25 Due: 07/31/26

Phase III Clinical Study of SHR-2004 Injection in Preventing Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty

Phase: N/A Priority: Normal
NCT ID: NCT06825416 Org: User:
Start: 03/14/25 End: 12/31/25 Due: 12/31/26

A Single Ascending Dose of HRS-4029 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT06905314 Org: User:
Start: 04/30/25 End: 12/31/25 Due: 12/31/26

Evaluate the Efficacy and Safety of SHR-1918 in Patients With Hyperlipidemic

Phase: N/A Priority: Normal
NCT ID: NCT06109831 Org: User:
Start: 11/24/23 End: 09/27/25 Due: 09/27/26

Study on the Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of SHR-2004 Injection in Adult Patients With Atrial Fibrillation

Phase: N/A Priority: Normal
NCT ID: NCT06280768 Org: User:
Start: 03/01/24 End: 12/31/24 Due: 12/31/25

SHR-2004 for the Prevention of Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty

Phase: N/A Priority: Normal
NCT ID: NCT05752461 Org: User:
Start: 04/12/23 End: 06/25/24 Due: 06/25/25

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Single-dose Injection of SHR-2004 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05369767 Org: User:
Start: 05/24/22 End: 01/30/23 Due: 01/30/24

Efficacy and Safety of SHR-1918 in Patients With Hyperlipidemia

Phase: N/A Priority: Normal
NCT ID: NCT06471218 Org: User:
Start: 07/02/24 End: 06/30/25 Due: 06/30/26

A Safety, Tolerability, Pharmacokinetic Study of SHR-6934 Injection in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT06700083 Org: User:
Start: 11/30/24 End: 08/31/25 Due: 08/31/26

A Trial of HRS8179 on Brain Swelling After Large Hemispheric Infarction

Phase: N/A Priority: Normal
NCT ID: NCT05690711 Org: User:
Start: 04/07/23 End: 02/27/24 Due: 02/27/25